Related references
Note: Only part of the references are listed.Gamma irradiation alters the phenotype and function of CD4+CD25+ regulatory T cells
Mengde Cao et al.
CELL BIOLOGY INTERNATIONAL (2009)
Hyperthermia and irradiation of head and neck squamous cancer cells causes migratory profile changes of tumour infiltrating lymphocytes
J. Schmidtner et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2009)
Regulatory T cells (Treg) in rheumatoid arthritis
Marie-Christophe Boissier et al.
JOINT BONE SPINE (2009)
Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination
Noriaki Nakai et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2009)
Systemic effects of local radiotherapy
Silvia C. Formenti et al.
LANCET ONCOLOGY (2009)
Enhanced functionality of CD4+CD25highFoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer
Junko Yokokawa et al.
CLINICAL CANCER RESEARCH (2008)
Presence of low dose of fludarabine in cultures blocks regulatory T cell expansion and maintains tumor-specific cytotoxic T lymphocyte activity generated with peripheral blood lymphocytes
Upendra Hegde et al.
PATHOBIOLOGY (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Local control by radiotherapy: is that all there is?
Silvia C. Formenti et al.
BREAST CANCER RESEARCH (2008)
Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine
Ji-Yan Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Radiation-induced apoptosis along with local and systemic cytokine elaboration is associated with DC plus radiotherapy-mediated renal cell tumor regression
Jianhua Huang et al.
CLINICAL IMMUNOLOGY (2007)
Self-tolerance, dendritic cell (DC)-mediated activation and tissue distribution of natural killer (NK) cells
Ivan Zanoni et al.
IMMUNOLOGY LETTERS (2007)
Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
Francois Ghiringhelli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
FOXP3 modifies the phenotypic and functional properties of regulatory T cells
Daniel J. Campbell et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Foxp3 occupancy and regulation of key target genes during T-cell stimulation
Alexander Marson et al.
NATURE (2007)
Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration
Laura Bracci et al.
CLINICAL CANCER RESEARCH (2007)
Exploiting regulatory T-cell populations for the immunotherapy of cancer
Hans J. J. van der Vliet et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients
Devi K. Banerjee et al.
BLOOD (2006)
Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms
Gregory Lizee et al.
CLINICAL CANCER RESEARCH (2006)
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Eric A. Reits et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Chemoimmunotherapy of tumors:: Cyclophosphamide synergizes with exosome based vaccines
Julien Taieb et al.
JOURNAL OF IMMUNOLOGY (2006)
Antitumor effects of systemic and local immunization with a CTL-directed peptide in combination with a local injection of OK-432
T Ono et al.
CLINICAL CANCER RESEARCH (2006)
Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide
L Höltl et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
MEC Lutsiak et al.
BLOOD (2005)
Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma
KW Chi et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
S Demaria et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation
M Okamoto et al.
CANCER RESEARCH (2004)
Foxp3 expressing CD4+CD25high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells
M Viguier et al.
JOURNAL OF IMMUNOLOGY (2004)
Cytokines in cancer immunity and immunotherapy
MJ Smyth et al.
IMMUNOLOGICAL REVIEWS (2004)
Cellular immunotherapy with dendritic cells in cancer: Current status
A Nencioni et al.
STEM CELLS (2004)
Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use
H Kuroki et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Rational approaches to human cancer immunotherapy
ID Davis et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
UK Liyanage et al.
JOURNAL OF IMMUNOLOGY (2002)
Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery
W Asavaroengchai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor β
K Nakamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients
A Gochi et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
